1-Hydroxy-3-Ethoxybenzene

1-Hydroxy-3-Ethoxybenzene

SCHEMBL365637

CCOc1cccc(O)c1

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.59
CHRNA4 P43681 2/20 0.59
CYP3A4 P08684 2/20 0.59
TP53 P04637 1/20 0.59
APP P05067 1/20 0.55
CHRNB4 P30926 3/20 0.50
CHRNA3 P32297 3/20 0.50
LTA4H P09960 2/20 0.50
FYN P06241 1/20 0.49
NLRP3 Q96P20 1/20 0.49
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
RXRA P19793 1/20 0.49
RXRB P28702 1/20 0.49
NQO1 P15559 1/20 0.48
MEN1 O00255 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
1-Hydroxy-3-Ethoxybenzene SCHEMBL30597483 1.00 CHRNB2 (0.59) CHRNB2CHRNA4CYP3A4TP53APP
1-Hydroxy-3-Ethoxybenzene SCHEMBL11135932 0.98 CHRNB2 (0.58) CHRNB2CHRNA4CYP3A4TP53APP
1-Hydroxy-3-Propoxybenzene SCHEMBL7605942 0.91 CHRNB2 (0.60) CHRNB2CHRNA4CYP3A4TP53APP
1-Hydroxy-3-Ethoxybenzene SCHEMBL8073061 0.91 CHRNB2 (0.51) CHRNB2CHRNA4CYP3A4TP53APP
1-Hydroxy-3-Ethoxybenzene SCHEMBL28060508 0.89 CYP3A4 (0.51) CHRNB2CHRNA4CYP3A4TP53APP
1-Hydroxy-3-Ethoxybenzene SCHEMBL8065289 0.89 CYP3A4 (0.73) CHRNB2CHRNA4CYP3A4TP53APP
1-Hydroxy-3-Ethoxybenzene SCHEMBL28103705 0.86 CHRNB2 (0.47) CHRNB2CHRNA4CYP3A4TP53APP
1-Hydroxy-3-Ethoxybenzene SCHEMBL9773989 0.85 CYP3A4 (0.67) CHRNB2CHRNA4CYP3A4TP53APP
1-Hydroxy-3-Propoxybenzene SCHEMBL6911642 0.85 CHRNB2 (0.54) CHRNB2CHRNA4CYP3A4TP53LTA4H
Benzophenone SCHEMBL28195163 0.85 LMNA (0.69) CYP3A4TP53KDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1957 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144739-A1 A SKIN BRIGHTENING COMPOSITION CONOPCO, INC., D/B/A UNILEVER (US) 2026-05-28 US claimed
EP-4682139-A1 AMMONIUM STYRENE SULFONATE COMPOSITION WITH EXCELLENT STORAGE STABILITY AND PRODUCTION METHOD THEREFOR Tosoh Finechem Corporation (JP) 2026-01-21 EP claimed
US-20260002924-A1 METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2026-01-01 US claimed
CN-116693727-B Catalyst for olefin polymerization and application thereof 中国石油化工股份有限公司 2025-05-06 CN claimed
CN-116693728-B Solid catalyst component, preparation method thereof, olefin polymerization catalyst and application thereof 中国石油化工股份有限公司 2025-05-06 CN claimed
CN-116285829-B Combined supermolecule adhesive resistant to ultralow temperature and organic solvent 陕西师范大学 2025-04-25 CN claimed
CN-116606390-B Olefin polymerization catalyst and application thereof 中国石油化工股份有限公司 2025-01-07 CN claimed
EP-4477693-A1 METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS Korea Research Institute of Chemical Technology (KR) 2024-12-18 EP claimed
US-20240398685-A1 A TOPICAL COMPOSITION FOR PROVIDING ENERGIZING GLOW ON SKIN CONOPCO, INC., D/B/A UNILEVER (US) 2024-12-05 US claimed
CN-116606391-B Olefin polymerization catalyst solid component, preparation method thereof, olefin polymerization catalyst and application 中国石油化工股份有限公司 2024-11-19 CN claimed
EP-0599688-B1 Process for O-alkylation of phenolic compounds RHONE POULENC CHIMIE (FR) 1997-08-27 EP claimed
EP-0773919-A1 METHOD FOR PREPARING 3-CARBOXY-4-HYDROXYBENZALDEHYDES AND DERIVATIVES THEREOF RHONE-POULENC CHIMIE (FR) 1997-05-21 EP claimed
EP-0465340-B2 Keratinous fibres dyeing process with 4-hydroxyindol at acidic pH and compositions OREAL (FR) 1997-03-05 EP claimed
WO-1996037454-A1 METHOD FOR PREPARING 3-CARBOXY-4-HYDROXYBENZALDEHYDES AND DERIVATIVES THEREOF RHONE-POULENC CHIMIE (FR) 1996-11-28 WO claimed
EP-0645435-A1 Trisazo dye, process for producing the same and aqueous ink composition containing the same ORIENT CHEMICAL INDUSTRIES, LTD. (JP) 1995-03-29 EP claimed
EP-0599688-A1 Process for O-alkylation of phenolic compounds RHONE-POULENC CHIMIE (FR) 1994-06-01 EP claimed
EP-0262061-B1 PROCESS FOR STABILIZING CHLORINATION MIXTURES OF PHENOL AND/OR CHLOROPHENOLS RHONE-POULENC CHIMIE (FR) 1993-02-24 EP claimed
US-4853153-A USING REDUCING AGENT AND CHLORINATED CYCLIC KETONE RHONE-POULENC CHIMIE (FR) 1989-08-01 US claimed
US-4473713-A Hydrolysis of aryl-aliphatic ethers RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1984-09-25 US claimed
US-4046503-A DEVELOPER-COUPLER HAIR DYES BASED ON ALKOXY-TRIAMINO-PYRIMIDINES HENKEL & CIE GMBH (DT) 1977-09-06 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260002924-A1 METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS FGB, NR4A1, CYP2E1 CHRNB2 270/4885CHRNA4 1031/4885CYP3A4 52/4885
US-20240398685-A1 A TOPICAL COMPOSITION FOR PROVIDING ENERGIZING GLOW ON SKIN PROC, CUTA, TYR CHRNB2 459/4885CHRNA4 1081/4885CYP3A4 2363/4885
US-20260144739-A1 A SKIN BRIGHTENING COMPOSITION CUTA, MYB, RBP4 CHRNB2 1496/4885CHRNA4 591/4885CYP3A4 573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.